Evolving Treatment Algorithms in Crohn's Disease

Author(s): Andrew Wisniewski, Silvio Danese, Laurent Peyrin-Biroulet*.

Journal Name: Current Drug Targets

Volume 19 , Issue 7 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Graphical Abstract:


Background: Crohn's disease (CD) is a chronic, disabling and destructive condition. Half of patients will develop some bowel damage (stricture, fistula and/or abscess). Current therapeutic strategies failed to alter its natural history.

Objective: We explore in a review article the evolution of CD treatment over a quarter of a century from a linear sequence of treatment intensification to a complex algorithm focused on individualized patient care by looking beyond symptoms. Specifically we focus on evolving concepts in assessing disease severity, selecting rigorous treatment end-targets, initiating an effective therapeutic therapy, and managing secondary loss of response.

Results: A tight monitoring of objective signs of inflammation and a treat-to-target approach are probably the only way to change patients' life and disease course. We now seek to optimize our therapeutic tools according to patient profile, disease phenotype and the unique pharmacodynamics that ensues.

Conclusion: Standardizing the clinical practice of gastroenteroogists with the most current treatment algorithm may minimize disease related complications while favouring patient’s quality of life.

Keywords: Crohn's disease, treat to target, anti-tnf, treatment algorithm, drug monitoring, mucosal healing.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [782 - 790]
Pages: 9
DOI: 10.2174/1389450117666160607075557
Price: $65

Article Metrics

PDF: 37
PRC: 1